Lisinopril and Hydrochlorothiazide
NDC 71610-274, Lisinopril and Hydrochlorothiazide, tablet, from Aphena Pharma Solutions - Tennessee, LLC.
- Product NDC
- 71610-274
- Status
- Listed
- Labeler
- Aphena Pharma Solutions - Tennessee, LLC
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA076194
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/71610-274 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- LISINOPRIL20 mg/1
- HYDROCHLOROTHIAZIDE12.5 mg/1
Pharmacologic classes
Angiotensin Converting Enzyme Inhibitor [EPC]; Angiotensin-converting Enzyme Inhibitors [MoA]; Increased Diuresis [PE]; Thiazide Diuretic [EPC]; Thiazides [CS]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 71610-274-80 | 71610027480 | 180 TABLET in 1 BOTTLE, PLASTIC (71610-274-80) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/5eea66bd-589a-45f8-ba2c-dea66a939d59
Use it
Look up 71610-274 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/71610-274 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 71610-274. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.